{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:57:54Z","timestamp":1792357074131,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1866,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bbmt.2009.11.004","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T00:43:10Z","timestamp":1257986590000},"page":"384-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial"],"prefix":"10.1016","volume":"16","author":[{"given":"Hirohisa","family":"Nakamae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn B.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.11.004_bib1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2003.03.129","article-title":"Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin","volume":"21","author":"Finke","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1705524","article-title":"Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8\/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin","volume":"38","author":"Sedlacek","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib3","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","article-title":"The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A-, HLA-B-, and HLA-DR-matched unrelated donors","volume":"99","author":"Morishima","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib4","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major histocompatibility complex class I alleles and antigens in hematopoietic cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.11.004_bib6","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib7","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies","volume":"102","author":"Maris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib8","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib9","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.2001.tb03601.x","article-title":"Nonmyeloablative hematopoietic cell transplantation: replacing high-dose cytotoxic therapy by the graft-versus-tumor effect","volume":"938","author":"Feinstein","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bbmt.2009.11.004_bib11","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","article-title":"Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma","volume":"104","author":"Maris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib12","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","article-title":"Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia","volume":"23","author":"Sorror","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib13","series-title":"Manual of Clinical Laboratory Immunology","first-page":"850","article-title":"Clinical bone marrow transplantation: donor selection and recipient monitoring","author":"Hansen","year":"1992"},{"key":"10.1016\/j.bbmt.2009.11.004_bib14","series-title":"Bone Marrow Transplantation","first-page":"22","article-title":"Histocompatibility","author":"Dupont","year":"1994"},{"key":"10.1016\/j.bbmt.2009.11.004_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00230505","article-title":"Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain","volume":"33","author":"Petersdorf","year":"1991","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2009.11.004_bib16","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2004-04-1674","article-title":"Limits of HLA mismatching in unrelated hematopoietic cell transplantation","volume":"104","author":"Petersdorf","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.11.004_bib18","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2007-03-078592","article-title":"Relapse risk among patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"110","author":"Kahl","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib19","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib20","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib21","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib22","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clim.2004.07.006","article-title":"Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)","volume":"113","author":"Storek","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib24","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/eji.1830231232","article-title":"Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life","volume":"23","author":"Klein","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib25","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood.V87.5.1873.1873","article-title":"Immunoglobulin heavy-chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest","volume":"87","author":"Suzuki","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"Klein","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2009.11.004_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2009.11.004_bib28","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood.V92.11.4464","article-title":"Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants","volume":"92","author":"Dumont-Girard","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib29","first-page":"413","article-title":"T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life","volume":"16","author":"Storek","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.150.2.429","article-title":"Both CD45RA+ and CD45RA- subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells","volume":"150","author":"Okumura","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/eji.1830230512","article-title":"Age-related accumulation of LFA-1high cells in a CD8+CD45RAhigh T cell population","volume":"23","author":"Okumura","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2005.12.030","article-title":"Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing","volume":"12","author":"Maris","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","article-title":"Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor","volume":"339","author":"Sasazuki","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.11.004_bib34","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.bmt.1704741","article-title":"Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors","volume":"35","author":"Greinix","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM199303043280901","article-title":"Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program","volume":"328","author":"Kernan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.11.004_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V81.2.543.543","article-title":"Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program","volume":"81","author":"McGlave","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib38","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib39","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2007.02.011","article-title":"Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant alemtuzumab","volume":"13","author":"Das Gupta","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2008.17.3328","article-title":"Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma","volume":"27","author":"Thomson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/01.TP.0000158718.49286.14","article-title":"In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem cell transplantation without ex vivo graft manipulation","volume":"79","author":"Kanda","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.11.004_bib43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.11.004_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib45","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with\u00a0nonmyeloablative conditioning","volume":"23","author":"Baron","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bbmt.2009.08.002","article-title":"A novel GVHD-prophylaxis with low-dose alemtuzumab in allogeneic sibling or unrelated donor hematopoetic cell transplantation: the feasibility of deescalation","volume":"15","author":"Bertz","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib47","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbmt.2009.03.017","article-title":"Comparison of tacrolimus and sirolimus (Tac\/Sir) versus tacrolimus, sirolimus, and mini-methotrexate (Tac\/Sir\/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"15","author":"Ho","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib48","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2006.07.004","article-title":"Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning","volume":"12","author":"Baron","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.11.004_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<82::AID-AJH3>3.0.CO;2-1","article-title":"Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease","volume":"52","author":"Storek","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2009.11.004_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V98.2.489","article-title":"Factors influencing B-lymphopoiesis after allogeneic hematopoietic cell transplantation","volume":"98","author":"Storek","year":"2001","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109005217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109005217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:45Z","timestamp":1761057345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109005217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1083879109005217"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}